0
     

Report Added
Report already added
Consumer Health in Switzerland

Consumer Health in Switzerland

Consumer health is registering positive growth in current value sales in 2022. The fear of COVID-19 is still lingering and continues to affect Swiss consumers’ behaviour towards OTC products. Products that were impacted by COVID-19, either positively or negatively, have come back to a more normal trajectory in terms of value growth.

Euromonitor International's Consumer Health in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Switzerland

List Of Contents And Tables

CONSUMER HEALTH IN SWITZERLAND
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 2 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2017-2022
Table 4 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 5 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 6 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 8 Distribution of Consumer Health by Format: % Value 2017-2022
Table 9 Distribution of Consumer Health by Format and Category: % Value 2022
Table 10 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Reverse Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Positive performance seen, despite lower influenza and other respiratory virus activity
Topical analgesics/anaesthetic is the best performer, thanks to aging population in the country
Generic analgesics remain a niche, despite the high prices of branded medicines
PROSPECTS AND OPPORTUNITIES
Positive outlook for analgesics set to extend over the forecast period, driven by pandemic fallout and demographics
Analgesics expected to reach maturity as a category, leading to saturation and limitations
Potential distribution deregulation could lead to wider sales and lower prices
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2017-2022
Table 13 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 14 NBO Company Shares of Analgesics: % Value 2018-2022
Table 15 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 16 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Small positive growth as hygiene and distancing measures weaken, but influenza activity remains low
Medicated confectionery sees the best performance in 2022
Growing prevalence of allergies helps to support overall category, compared to lower incidences of coughs and colds
PROSPECTS AND OPPORTUNITIES
Positive outlook expected, with medicated confectionery remaining popular and allergies driving sales
Self-medication to favourably impact overall category growth
Competitive landscape to remain fragmented but dynamic
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
DIGESTIVE REMEDIES IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Modest value growth seen, due to price wars within the category headed by leading brand
IBS treatments sees the best performance, due to growing from a low base
Parents’ concern about potential side effects of paediatric digestive remedies and the search for more natural solutions negatively impacts category
PROSPECTS AND OPPORTUNITIES
Mature category expected to see sluggish positive sales
Overall health and wellness trends to limit growth in digestive remedies
Janssen-Cilag expected to remain number one player with popular brand Imodium
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2017-2022
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 26 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
DERMATOLOGICALS IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Growth in dermatologicals continues, in line with the return to more social lifestyles
Hair loss treatments maintains best performance, as other categories also benefit from out-of-home activities
Bayer (Schweiz) AG maintains its top place, thanks to popularity of its Bepanthen and Canesten brands
PROSPECTS AND OPPORTUNITIES
Ongoing positive growth, in line with various rising factors which can cause skin irritations
Trend for natural products will somewhat suppress stronger growth in traditional dermatologicals
Multinationals will continue to dominate dermatologicals, thanks to their myriad strengths
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2017-2022
Table 31 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 32 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 33 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
Table 35 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
NRT SMOKING CESSATION AIDS IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Modest positive performance seen, as the high number of smokers in Switzerland slowly declines
Janssen-Cilag’s Nicorette brand maintains its top place with the lion’s share of sales
Competition from “reduced-risk products” suppresses stronger growth
PROSPECTS AND OPPORTUNITIES
Slow growth expected, in line with gradually reducing number of smokers in the country
Innovation expected in flavours and packaging, to compete with the rising trends for vaping and heated tobacco
Holistic smoking cessation trends arise, from hypnotherapy to laser therapy
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
SLEEP AIDS IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sleep aids continue to benefit from consumers’ stress, from COVID-19 to global inflation and financial uncertainty
Interest in more natural alternatives continues to grow, as consumers prefer gentler methods of sleep aids
Sidroga AG maintains top place as consumers continue to purchase the brands they know and trust
PROSPECTS AND OPPORTUNITIES
Growth expected in line with ongoing consumer anxieties and stress causing sleep disturbances
Sustained focus on natural products and more segmentation expected
No change in distribution channels expected in the short-term, but longer-term prospects may change sales landscape
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2017-2022
Table 45 Sales of Sleep Aids: % Value Growth 2017-2022
Table 46 NBO Company Shares of Sleep Aids: % Value 2018-2022
Table 47 LBN Brand Shares of Sleep Aids: % Value 2019-2022
Table 48 Forecast Sales of Sleep Aids: Value 2022-2027
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
EYE CARE IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Allergy prevalence drives sales of allergy eye care – particularly during high-pollen season
Increased screen time drives demand for standard eye care
Théa Pharma SA maintains its lead, thanks to strong brand portfolio and high reputation
PROSPECTS AND OPPORTUNITIES
Extended screen time and an aging population will support eye care sales over the forecast period
The increase in environmental allergens will increase demand for allergy eye care
Category saturation and maturity drives players to ensure their brands stand out
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2017-2022
Table 51 Sales of Eye Care by Category: % Value Growth 2017-2022
Table 52 NBO Company Shares of Eye Care: % Value 2018-2022
Table 53 LBN Brand Shares of Eye Care: % Value 2019-2022
Table 54 Forecast Sales of Eye Care by Category: Value 2022-2027
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2022-2027
WOUND CARE IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Outdoor activities due to warm weather drives demand for wound care, as consumers are more likely to sustain minor injuries
Wide private label offerings face competition from the leading branded players
Distribution of wound care remains unchanged in 2022
PROSPECTS AND OPPORTUNITIES
Sales in wound care to grow in line with ongoing consumer demand, with outdoor and sporting lifestyles boosting demand for plasters
Multinationals expected to continue dominating wound care, while private labels still maintain a presence
Innovation to remain key, with increasing competition expected in new product developments
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2017-2022
Table 57 Sales of Wound Care by Category: % Value Growth 2017-2022
Table 58 NBO Company Shares of Wound Care: % Value 2018-2022
Table 59 LBN Brand Shares of Wound Care: % Value 2019-2022
Table 60 Forecast Sales of Wound Care by Category: Value 2022-2027
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2022-2027
VITAMINS IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Vitamins continue to benefit from health and wellness trends, enhanced by the time of COVID-19
Multivitamins see boost due to resumption of busy lifestyles, whilst vitamin C remains popular
Pharmacies remain the most popular channel due to consumers’ trust in professional advice
PROSPECTS AND OPPORTUNITIES
Vitamins will continue to grow in line with rising health and wellness trends
Bayer and Antistress expected to maintain leading places over the forecast period
No notable channel changes expected, albeit e-commerce will slowly grow in relevance
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2017-2022
Table 63 Sales of Vitamins by Category: % Value Growth 2017-2022
Table 64 Sales of Multivitamins by Positioning: % Value 2017-2022
Table 65 NBO Company Shares of Vitamins: % Value 2018-2022
Table 66 LBN Brand Shares of Vitamins: % Value 2019-2022
Table 67 Forecast Sales of Vitamins by Category: Value 2022-2027
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2022-2027
DIETARY SUPPLEMENTS IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Health and wellness trends support sales, whilst competition comes from fortified/functional packaged food
Active lifestyles and an aging population support sales
Domestic Antistress AG maintains lead, thanks to high levels of consumer trust and a wide and innovative portfolio
PROSPECTS AND OPPORTUNITIES
Category saturation expected, whilst health and wellness trends continue to support growth
Healthier lifestyles and competition from alternatives look set to threaten growth
Crucial for players to follow consumer trends to see successful sales
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2017-2022
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2017-2022
Table 71 Sales of Dietary Supplements by Positioning: % Value 2017-2022
Table 72 NBO Company Shares of Dietary Supplements: % Value 2018-2022
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2019-2022
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2022-2027
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2022-2027
WEIGHT MANAGEMENT AND WELLBEING IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sales supported by consumers still seeking to shed their “lockdown weight gains”
Convenience and clarity are the main drivers for successful products
Domestic Biomed and Wander maintain their top places thanks to strong consumer loyalty
PROSPECTS AND OPPORTUNITIES
Low-level growth expected, in line with consumers’ busy lifestyles and health goals
Convenience and trust continue to play major roles, although growing competition could suppress sales
Distribution channels set to grow, from supermarkets through to e-commerce
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2017-2022
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2018-2022
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2019-2022
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2022-2027
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2022-2027
SPORTS NUTRITION IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sports nutrition benefits from health and wellbeing trends as a higher number of consumers take up regular exercise
Widening distribution supports growing mass consumer appeal
Specialists regain traction and e-commerce continues to establish itself, especially for repeat sales
PROSPECTS AND OPPORTUNITIES
Widening awareness and distribution will support sales over the forecast period
Domestic Sponsor Sport Food maintains company lead, whilst Active Nutrition’s PowerBar shows rising competition
Growing competition from fortified and functional foods expected
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2017-2022
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2017-2022
Table 84 NBO Company Shares of Sports Nutrition: % Value 2018-2022
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2019-2022
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2022-2027
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2022-2027
HERBAL/TRADITIONAL PRODUCTS IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Herbal/traditional products maintain positive growth due to healthier image, however medical authorities warn against prolonged use
Evolving trends in subcategories based on lingering pandemic effects and a health-conscious focus
Procter & Gamble maintains lead with Vicks brand, in a highly fragmented category
PROSPECTS AND OPPORTUNITIES
Sales to be supported by ongoing health and wellness trends, along with the rising popularity of CBD
Stress and hectic lifestyles will continue to drive demand for herbal/traditional sleep aids
Homoeopathic remedies to likely hamper stronger growth for herbal/traditional products
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2017-2022
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2018-2022
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2019-2022
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2022-2027
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2022-2027
PAEDIATRIC CONSUMER HEALTH IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Modest growth due to parents preferring to seek medical advice for their children
Paediatric analgesics and paediatric digestive remedies decline, due to parents being cautious about OTC for their children
PROSPECTS AND OPPORTUNITIES
Flat growth expected over the forecast period, due to ongoing parental caution
Galderma to remain the leading player in paediatric consumer health
The fear of future pandemics will likely benefit sales of paediatric vitamins and dietary supplements
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027

Report Title: Consumer Health in Switzerland


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW